{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:45:04Z","timestamp":1790876704000,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022571","name":"Nirma University Institute of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arr.2024.102208","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T12:30:45Z","timestamp":1706531445000},"page":"102208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["An update on new-age potential biomarkers for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-3941","authenticated-orcid":false,"given":"Ritu","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102208_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease","author":"Alecu","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2024.102208_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/imr.12519","article-title":"LAG3 (CD223) as a cancer immunotherapy target","author":"Andrews","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.arr.2024.102208_bib3","article-title":"Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson\u2019s disease: molecular mechanisms connecting neuroinflammation to \u03b1-synuclein spreading pathology","author":"Angelopoulou","year":"2020","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.arr.2024.102208_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-023-11893-x","article-title":"Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson\u2019s disease","author":"Angius","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102208_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.parkreldis.2011.03.004","article-title":"Retinal thickness in Parkinson\u2019s disease","volume":"17","author":"Archibald","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102208_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00401-019-02063-3","article-title":"Early defects in translation elongation factor 1\u03b1 levels at excitatory synapses in \u03b1-synucleinopathy","volume":"138","author":"Blumenstock","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102208_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-019-02062-4","article-title":"Salivary alpha-synuclein as a biomarker for Parkinson\u2019s disease: a systematic review","author":"Bougea","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2024.102208_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-023-01653-3","article-title":"Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders","volume":"11","author":"Br\u00e4uer","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102208_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-020-00656-8","article-title":"LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson\u2019s disease","volume":"13","author":"Cai","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.arr.2024.102208_bib11","doi-asserted-by":"crossref","DOI":"10.1515\/revneuro-2018-0064","article-title":"Alpha-synuclein in salivary gland as biomarker for Parkinson\u2019s disease","author":"Campo","year":"2019","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102208_bib12","article-title":"Lipid pathway alterations in parkinson\u2019s disease primary visual cortex","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102208_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.parkreldis.2021.02.007","article-title":"Association of lipid levels with motor and cognitive function and decline in advanced Parkinson\u2019s disease in the Mark-PD study","volume":"85","author":"Choe","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2015.05.007","article-title":"Characterization of retinal architecture in Parkinson\u2019s disease","volume":"355","author":"Chorostecki","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102208_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2011.09.012","article-title":"Microglial signalling mechanisms: cathepsin S and fractalkine","author":"Clark","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102208_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2021.03.009","article-title":"The pseudogenes of eukaryotic translation elongation factors (EEFs): role in cancer and other human diseases","author":"Cristiano","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.arr.2024.102208_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mds.27569","article-title":"Serum soluble lymphocyte activation gene-3 as a diagnostic biomarker in Parkinson\u2019s disease: a pilot multicenter study","volume":"34","author":"Cui","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/metabo13090990","article-title":"Serum-based lipid panels for diagnosis of idiopathic Parkinson\u2019s disease","volume":"13","author":"Dahabiyeh","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.arr.2024.102208_bib19","doi-asserted-by":"crossref","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.arr.2024.102208_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med"},{"key":"10.1016\/j.arr.2024.102208_bib21","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102208_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000000028","article-title":"Retina measurements for diagnosis of parkinson disease","author":"Garcia-Martin","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.arr.2024.102208_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13847","article-title":"Association between LAG3\/CD4 gene variants and risk of Parkinson\u2019s disease","volume":"52","author":"Garc\u00eda-Mart\u00edn","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.arr.2024.102208_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2009.08.150","article-title":"Abnormal serum concentrations of proteins in Parkinson\u2019s disease","volume":"389","author":"Goldknopf","year":"2009","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.arr.2024.102208_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3109\/00207454.2014.979288","article-title":"The serum lipid profile of Parkinson\u2019s disease patients: A study from China","volume":"125","author":"Guo","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.arr.2024.102208_bib26","article-title":"Defining specific cell states of MPTP-induced Parkinson\u2019s disease by single-nucleus RNA sequencing","volume":"23","author":"Guo","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102208_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-013-1028-y","article-title":"MALAT1 - a paradigm for long noncoding RNA function in cancer","author":"Gutschner","year":"2013","journal-title":"J. Mol. Med"},{"key":"10.1016\/j.arr.2024.102208_bib28","first-page":"1","article-title":"Parkinson\u2019s disease identification and evaluation using nocturnal breathing signals with artificial intelligence corresponding author*","volume":"2022","author":"Harper","year":"2022","journal-title":"Int J. Collab. Res Intern Med Public Health"},{"key":"10.1016\/j.arr.2024.102208_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2741\/3628","article-title":"DNA induced folding\/fibrillation of alpha-synuclein: new insights in Parkinson\u2019s disease","volume":"15","author":"Hegde","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.arr.2024.102208_bib30","first-page":"42","article-title":"LncRNA MALAT1 affects the biological behavior of Parkinson\u2019s disease model cells by downregulating miR-181a","volume":"13","author":"Jianfu","year":"2020","journal-title":"Int J. Clin. Exp. Med"},{"key":"10.1016\/j.arr.2024.102208_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2007.04.044","article-title":"CIP2A inhibits PP2A in human malignancies","volume":"130","author":"Junttila","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102208_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid \u03b1-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib33","article-title":"Salivary total \u03b1-synuclein, oligomeric \u03b1-synuclein and SNCA variants in Parkinson\u2019s disease patients","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102208_bib34","article-title":"Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease","volume":"3","author":"Karayel","year":"2022","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.arr.2024.102208_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031842","article-title":"Searching for biomarkers in the blood of patients at risk of developing Parkinson\u2019s disease at the prodromal stage","volume":"24","author":"Katunina","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102208_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031842","article-title":"Searching for biomarkers in the blood of patients at risk of developing Parkinson\u2019s disease at the prodromal stage","volume":"24","author":"Katunina","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102208_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/agm2.12192","article-title":"Salivary alpha-synuclein as a potential fluid biomarker in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"5","author":"Kharel","year":"2022","journal-title":"Aging Med."},{"key":"10.1016\/j.arr.2024.102208_bib38","article-title":"Comparative mRNA expression of eEF1A isoforms and a PI3K\/Akt\/mTOR pathway in a cellular model of Parkinson\u2019s disease","volume":"2016","author":"Khwanraj","year":"2016","journal-title":"Park. Dis."},{"key":"10.1016\/j.arr.2024.102208_bib39","article-title":"Identification of biomarkers associated with Parkinson\u2019s disease by gene expression profiling studies and bioinformatics analysis","author":"Krokidis","year":"2019","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.arr.2024.102208_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020329","article-title":"Update on CSF biomarkers in Parkinson\u2019s Disease","author":"Kwon","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102208_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/chemosensors11060317","article-title":"The role of nano-sensors in breath analysis for early and non-invasive disease diagnosis","author":"Lagopati","year":"2023","journal-title":"Chemosensors"},{"key":"10.1016\/j.arr.2024.102208_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","article-title":"Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease","volume":"18","author":"Lee","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102208_bib43","first-page":"15","article-title":"Respiratory dysfunction in Parkinson\u2019s disease","author":"Lee","year":"2021","journal-title":"Clin. Chest Med"},{"key":"10.1016\/j.arr.2024.102208_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2010.11.068","article-title":"Parkinson\u2019s disease involves autophagy and abnormal distribution of cathepsin L","volume":"489","author":"Li","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102208_bib45","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/CMAR.S169406","article-title":"MALAT1: a potential biomarker in cancer","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.arr.2024.102208_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(19)30195-4","article-title":"Parkinson\u2019s disease in the Western Pacific Region","author":"Lim","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102208_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-017-0147-5","article-title":"Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease","volume":"7","author":"Liu","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.arr.2024.102208_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2007.11.027","article-title":"Secretion of DJ-1 into the serum of patients with Parkinson\u2019s disease","volume":"431","author":"Maita","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102208_bib49","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/mds.26754","article-title":"Longitudinal changes in CSF alpha-synuclein species reflect Parkinson\u2019s disease progression","volume":"31","author":"Majbour","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib50","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson\u2019s disease: features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.arr.2024.102208_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2018.06.016","article-title":"Retinal changes in Parkinson\u2019s disease and glaucoma","volume":"56","author":"Matlach","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib52","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1074\/jbc.RA119.008930","article-title":"C-terminal \u03b1-synuclein truncations are linked to cysteine cathepsin activity in Parkinson\u2019s disease","volume":"294","author":"McGlinchey","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102208_bib53","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","article-title":"Biomarkers of Parkinson\u2019s disease: present and future","volume":"64","author":"Miller","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.arr.2024.102208_bib54","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-020-01274-w","article-title":"Does retina play a role in Parkinson\u2019s Disease?","author":"Mohana Devi","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.arr.2024.102208_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2021.07.007","article-title":"Multimodal retinal imaging to detect and understand Alzheimer\u2019s and Parkinson\u2019s disease","author":"Moons","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.arr.2024.102208_bib56","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.29880","article-title":"Prospect of alpha-synuclein (A-Syn) isolation from saliva as a promising diagnostic biomarker alternative in Parkinson\u2019s disease (PD): a systematic review","author":"Muddaloor","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.arr.2024.102208_bib57","doi-asserted-by":"crossref","DOI":"10.2217\/nnm.14.121","article-title":"Monolayer-capped gold nanoparticles for disease detection from breath","author":"Nakhleh","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2024.102208_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2022.100067","article-title":"The eEF1 family of mammalian translation elongation factors","volume":"3","author":"Negrutskii","year":"2023","journal-title":"BBA Adv."},{"key":"10.1016\/j.arr.2024.102208_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/mds.27897","article-title":"CSF or serum neurofilament light added to \u03b1-synuclein panel discriminates Parkinson\u2019s from controls","volume":"35","author":"Oosterveld","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib60","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in parkinson\u2019s disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.arr.2024.102208_bib61","first-page":"21","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.arr.2024.102208_bib62","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awab431","article-title":"Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies","volume":"145","author":"Poggiolini","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102208_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neures.2020.03.013","article-title":"Effects of eEF1A2 knockdown on autophagy in an MPP+-induced cellular model of Parkinson\u2019s disease","volume":"164","author":"Prommahom","year":"2021","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.arr.2024.102208_bib64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1873-3468.14030","article-title":"Cytosolic PINK1 orchestrates protein translation during proteasomal stress by phosphorylating the translation elongation factor eEF1A1","volume":"595","author":"Qin","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102208_bib65","doi-asserted-by":"crossref","unstructured":"Recasens, A., Neuroanatomy, B.D.-F. in, 2014, undefined, n.d. Alpha-synuclein spreading in Parkinson\u2019s disease. frontiersin.org.","DOI":"10.3389\/fnana.2014.00159"},{"key":"10.1016\/j.arr.2024.102208_bib66","doi-asserted-by":"crossref","DOI":"10.1159\/000314478","article-title":"Clinical criteria for the diagnosis of Parkinson\u2019s disease","author":"Reichmann","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2024.102208_bib67","series-title":"in: JAMA Ophthalmology","first-page":"182","article-title":"Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease","author":"Robbins","year":"2021"},{"key":"10.1016\/j.arr.2024.102208_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102208_bib69","article-title":"High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease","volume":"9","author":"Russo","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102208_bib70","first-page":"155","article-title":"Serum lipid profile of Parkinson\u2019s disease patients: A study from the Northwest of Iran","volume":"12","author":"Saedi","year":"2021","journal-title":"Casp. J. Intern Med"},{"key":"10.1016\/j.arr.2024.102208_bib71","series-title":"in: Advances in Experimental Medicine and Biology","first-page":"149","article-title":"DJ-1 as a biomarker of Parkinson\u2019s disease","author":"Saito","year":"2017"},{"key":"10.1016\/j.arr.2024.102208_bib72","series-title":"in: Advances in Experimental Medicine and Biology","first-page":"149","article-title":"DJ-1 as a biomarker of Parkinson\u2019s disease","author":"Saito","year":"2017"},{"key":"10.1016\/j.arr.2024.102208_bib73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10571-019-00734-z","article-title":"PARK2 and PARK7 gene polymorphisms as risk factors associated with serum element concentrations and clinical symptoms of Parkinson\u2019s disease","volume":"40","author":"Sanyal","year":"2020","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102208_bib74","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/glia.23077","article-title":"Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1\u2013Cx3cr1 axis in a Niemann\u2013Pick disease type C1 model","volume":"64","author":"Seo","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.arr.2024.102208_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s41983-020-0159-7","article-title":"Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson\u2019s disease","volume":"56","author":"Shaheen","year":"2020","journal-title":"Egypt. J. Neurol., Psychiatry Neurosurg."},{"key":"10.1016\/j.arr.2024.102208_bib76","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181335","article-title":"LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis","volume":"39","author":"Shaker","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.arr.2024.102208_bib77","doi-asserted-by":"crossref","unstructured":"Simon, D.K., Tanner, C.M., Brundin, P., 2019. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.","DOI":"10.1016\/j.cger.2019.08.002"},{"key":"10.1016\/j.arr.2024.102208_bib78","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.2c00165","article-title":"Deciphering intertwined molecular pathways underlying metabolic syndrome leading to Parkinson\u2019s disease","author":"Soni","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102208_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2020.107734","article-title":"A nano-composite based regenerative neuro biosensor sensitive to Parkinsonism-associated protein DJ-1\/Park7 in cerebrospinal fluid and saliva","volume":"138","author":"Sonu\u00e7 Karabo\u011fa","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.arr.2024.102208_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-synuclein aggregation in Parkinson\u2019s disease","author":"Srinivasan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arr.2024.102208_bib81","article-title":"Potential role of retina as a biomarker for progression of Parkinson\u2019s disease","author":"Tian","year":"2011","journal-title":"Int J. Ophthalmol."},{"key":"10.1016\/j.arr.2024.102208_bib82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/cn200093r","article-title":"Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors","volume":"3","author":"Tisch","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102208_bib83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/nnm.12.105","article-title":"Detection of Alzheimer\u2019s and Parkinson\u2019s disease from exhaled breath using nanomaterial-based sensors","volume":"8","author":"Tisch","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2024.102208_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102208_bib85","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2024.102208_bib86","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03164","article-title":"The translation elongation factor eEF1A1 couples transcription to translation during heat shock response","volume":"3","author":"Vera","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.arr.2024.102208_bib87","article-title":"The prion hypothesis in Parkinson\u2019s disease: braak to the future","volume":"1","author":"Visanji","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102208_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal salivary total and oligomeric alpha-synuclein in Parkinson\u2019s disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102208_bib89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","article-title":"Salivary alpha-synuclein in the diagnosis of Parkinson\u2019s disease and progressive supranuclear palsy","volume":"63","author":"Vivacqua","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102208_bib90","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2020.3311","article-title":"Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease","volume":"78","author":"Wang","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102208_bib91","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2015-0114","article-title":"Cathepsin S: therapeutic, diagnostic, and prognostic potential","author":"Wilkinson","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.arr.2024.102208_bib92","article-title":"A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson\u2019s disease","volume":"8","author":"Xiang","year":"2022","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2024.102208_bib93","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/iji.12549","article-title":"LncRNA MALAT1 potentiates inflammation disorder in Parkinson\u2019s disease","volume":"48","author":"Yang","year":"2021","journal-title":"Int J. Immunogenet."},{"key":"10.1016\/j.arr.2024.102208_bib94","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/s41591-022-01932-x","article-title":"Artificial intelligence-enabled detection and assessment of Parkinson\u2019s disease using nocturnal breathing signals","volume":"28","author":"Yang","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2024.102208_bib95","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s12035-021-02670-w","article-title":"Cancerous inhibitor of protein phosphatase 2A (CIP2A): could it be a promising biomarker and therapeutic target in Parkinson\u2019s disease?","volume":"59","author":"Yin","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102208_bib96","article-title":"Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson\u2019s disease: a preliminary study","volume":"16","author":"Yuan Zhao","year":"2022","journal-title":"Proteom. Clin. Appl."},{"key":"10.1016\/j.arr.2024.102208_bib97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2016.06.017","article-title":"Beta-asarone protects against MPTP-induced Parkinson\u2019s disease via regulating long non-coding RNA MALAT1 and inhibiting \u03b1-synuclein protein expression","volume":"83","author":"Zhang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2024.102208_bib98","doi-asserted-by":"crossref","DOI":"10.1080\/15476286.2017.1358347","article-title":"The long noncoding RNA Malat1: Its physiological and pathophysiological functions","author":"Zhang","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.arr.2024.102208_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.arr.2024.102208_bib100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000520102","article-title":"Identification of novel biomarkers in platelets for Diagnosing Parkinson's disease","volume":"85","author":"Zhang","year":"2022","journal-title":"Eur Neurol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:12:42Z","timestamp":1761592362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":100,"alternative-id":["S1568163724000266"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102208","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on new-age potential biomarkers for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102208"}}